Cytokine gene variants and venous thrombotic risk in the BRATROS (BRAZILIAN THROMBOSIS STUDY)


Autoria(s): Pieroni, Fabiano; Lourenço, Dayse M.; Morelli, Vânia M.; Maffei, Francisco Humberto de Abreu; Zago, Marco A.; Franco, Rendrik F.
Contribuinte(s)

Universidade Estadual Paulista (UNESP)

Data(s)

27/05/2014

27/05/2014

21/05/2007

Resumo

Introduction: Venous thrombosis (VT) and inflammation are two closely related entities. In the present investigation we assessed whether there is a relation between genetic modifiers of the inflammatory response and the risk of VT. Materials and methods: 420 consecutive and unrelated patients with an objective diagnosis of deep VT and 420 matched controls were investigated. The frequencies of the following gene polymorphisms were determined in all subjects: TNF-α- 308 G/A, LT-α+ 252 A/G, IL-6-174 G/C, IL1-ra 86 bp VNTR, IL-10-1082 A/G and CD-31 125 C/G. Results: Overall odds ratio (OR) for VT related to TNF-α- 308 G/A, LT-α+ 252 A/G, IL-6-174 G/C, A1 allele (4 bp repeat) of the IL1-ra 86 bp VNTR, IL-10-1082 A/G and CD-31 125 C/G were respectively: 1.0 (CI95: 0.8-1.5), 1.3 (CI95: 1.0-1.7), 1.1 (CI95: 0.9-1.5), 1.6 (CI95: 1-2.5), 1.2 (CI95: 0.8-1.7) and 0.8 (CI95: 0.6-1.1). A possible interaction between polymorphisms was observed only for the co-inheritance of the mutant alleles of the LT-α+ 252 A/G and IL-10-1082 G/A polymorphisms (OR = 2; CI95: 1.1-3.8). The risk of VT conferred by factor V Leiden and FII G20210A was not substantially altered by co-inheritance with any of the cytokine gene polymorphisms. Conclusions: Cytokine gene polymorphisms here investigated did not significantly influence venous thrombotic risk. © 2006 Elsevier Ltd. All rights reserved.

Formato

221-229

Identificador

http://dx.doi.org/10.1016/j.thromres.2006.09.015

Thrombosis Research, v. 120, n. 2, p. 221-229, 2007.

0049-3848

http://hdl.handle.net/11449/69670

10.1016/j.thromres.2006.09.015

2-s2.0-34248512217

Idioma(s)

eng

Relação

Thrombosis Research

Direitos

closedAccess

Palavras-Chave #Coagulation #Cytokines #Inflammation #Polymorphisms #Thrombosis #Venous thromboembolism #blood clotting factor 11 #blood clotting factor 5 Leiden #CD31 antigen #cytokine #interleukin 1 receptor blocking agent #interleukin 10 #interleukin 6 #lymphotoxin #tumor necrosis factor alpha #cardiovascular risk #deep vein thrombosis #genetic polymorphism #inflammation #major clinical study #medical research #Base Sequence #Case-Control Studies #DNA Primers #Interleukin 1 Receptor Antagonist Protein #Interleukin-10 #Interleukin-6 #Lymphotoxin-alpha #Middle Aged #Odds Ratio #Polymorphism, Genetic #Tumor Necrosis Factor-alpha #Variation (Genetics) #Venous Thrombosis
Tipo

info:eu-repo/semantics/article